IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells

Doxorubicin (Dox) is the standard treatment approach for osteosarcoma (OS), while acquired drug resistance seriously attenuates its treatment efficiency. The present study aimed to investigate the potential roles of metabolic reprogramming and the related regulatory mechanism in Dox-resistant OS cel...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qing, Hao, Peng, He, Gang, Mai, Hantao, Liu, Wenzhou, Zhang, Weiqiong, Zhang, Kelin, Zhong, Guifang, Guo, Ruilian, Yu, Changzhi, Li, Yang, Wong, Chipiu, Chen, Qian, Chen, Yantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344706/
https://www.ncbi.nlm.nih.gov/pubmed/35918761
http://dx.doi.org/10.1186/s12967-022-03549-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344706/
https://www.ncbi.nlm.nih.gov/pubmed/35918761
http://dx.doi.org/10.1186/s12967-022-03549-7

Ejemplares similares